If you're looking for dividend stocks that offer both attractive yields and strong growth prospects, you might want to consider (NYSE: ABBV) and Bristol Myers Squibb (NYSE: BMY). Both of these healthcare giants have impressive track records of rewarding shareholders with consistent dividend payments and increases, as well as robust pipelines of innovative drugs that could drive future earnings growth. Equally as important, both stocks trade at a substantial discount relative to their pharmaceutical peer group.

Here's why AbbVie and Bristol Myers Squibb screen as two undervalued dividend stocks to buy now.

Image Source: Getty Images.

Continue reading

Source Fool.com